These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 9776269)
21. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981 [TBL] [Abstract][Full Text] [Related]
22. Metabolism of radioiodinated fatty acid analogs in ischemic and hypoxic canine myocardium. Sloof GW; Visser FC; Comans EF; Bax JJ; Teerlink T; van der Vusse GJ; Knapp FF J Nucl Med; 1999 Jul; 40(7):1204-15. PubMed ID: 10405143 [TBL] [Abstract][Full Text] [Related]
23. BMIPP compared with PET metabolism. Tadamura E; Tamaki N; Kudoh T; Hattori N; Konishi J Int J Card Imaging; 1999 Feb; 15(1):61-9. PubMed ID: 10453404 [TBL] [Abstract][Full Text] [Related]
24. Differences in fatty acid metabolic disorder between ischemic myocardium and doxorubicin-induced myocardial damage: assessment using BMIPP dynamic SPECT with analysis by the Rutland method. Kitagawa K; Takeda K; Saito K; Okamoto S; Makino K; Maeda H; Ichihara T J Nucl Med; 2002 Oct; 43(10):1286-94. PubMed ID: 12368365 [TBL] [Abstract][Full Text] [Related]
25. Accelerated BMIPP uptake immediately after reperfused ischemia in the isolated rat heart model. Fukushima K; Momose M; Kondo C; Hagiwara N; Sakai S Ann Nucl Med; 2011 Oct; 25(8):560-5. PubMed ID: 21732040 [TBL] [Abstract][Full Text] [Related]
27. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids. DeGrado TR; Kitapci MT; Wang S; Ying J; Lopaschuk GD J Nucl Med; 2006 Jan; 47(1):173-81. PubMed ID: 16391202 [TBL] [Abstract][Full Text] [Related]
28. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. Nohara R; Okuda K; Ogino M; Hosokawa R; Tamaki N; Konishi J; Fujibayashi Y; Yonekura Y; Fujita M; Sasayama S J Nucl Med; 1996 Aug; 37(8):1403-7. PubMed ID: 8708784 [TBL] [Abstract][Full Text] [Related]
31. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid]. Mori H; Sakamoto T; Ueda Y; Yano K J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of myocardial perfusion and fatty acid uptake using a single injection of iodine-123-BMIPP in patients with acute coronary syndromes. Kobayashi H; Kusakabe K; Momose M; Okawa T; Inoue S; Iguchi N; Hosoda S J Nucl Med; 1998 Jul; 39(7):1117-22. PubMed ID: 9669379 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and metabolism of the methyl-branched fatty acid (BMIPP) in animals and humans. Kropp J; Eisenhut M; Ambrose KR; Knapp FF; Franke WG J Nucl Med; 1999 Sep; 40(9):1484-91. PubMed ID: 10492369 [TBL] [Abstract][Full Text] [Related]
34. Fatty acid myocardial imaging using 123I-beta-methyl-iodophenyl pentadecanoic acid (BMIPP): comparison of myocardial perfusion and fatty acid utilization in canine myocardial infarction (occlusion and reperfusion model). Nishimura T; Sago M; Kihara K; Oka H; Shimonagata T; Katabuchi T; Hayashi M; Uehara T; Hayashida K; Noda H Eur J Nucl Med; 1989; 15(7):341-5. PubMed ID: 2776792 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of fatty acid metabolism in hearts after ischemia-reperfusion injury using a dual-isotope autoradiographic approach and tissue assay for metabolites of tracer. Igarashi N; Nozawa T; Fujii N; Kato B; Nonomura M; Matsuki A; Nakadate T; Igawa A; Asanoi H; Inoue M; Inoue H J Nucl Med; 2005 Jan; 46(1):160-4. PubMed ID: 15632047 [TBL] [Abstract][Full Text] [Related]
36. Absent myocardial accumulation of two different radioiodinated pentadecanoic acids. Hashimoto J; Koseki S; Kinoshita F; Kubo A; Iwanaga S; Mitamura H; Ogawa S Ann Nucl Med; 1998 Feb; 12(1):43-6. PubMed ID: 9559961 [TBL] [Abstract][Full Text] [Related]
37. Dual-label studies with [125I]-3(R)/[131I]-3(S)-BMIPP show similar metabolism in rat tissues. Mokler FT; Lin Q; Luo H; McPherson DW; Beets AL; Bockisch A; Kropp J; Knapp FF J Nucl Med; 1999 Nov; 40(11):1918-27. PubMed ID: 10565790 [TBL] [Abstract][Full Text] [Related]
38. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid]. Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of radioiodinated fatty acid myocardial imaging agents in animal models and human studies. Knapp FF; Kropp J; Franken PR; Visser FC; Sloof GW; Eisenhut M; Yamamichi Y; Shirakami Y; Kusuoka H; Nishimura T Q J Nucl Med; 1996 Sep; 40(3):252-69. PubMed ID: 8961803 [TBL] [Abstract][Full Text] [Related]
40. Metabolism of iodine-123-BMIPP in perfused rat hearts. Yamamichi Y; Kusuoka H; Morishita K; Shirakami Y; Kurami M; Okano K; Itoh O; Nishimura T J Nucl Med; 1995 Jun; 36(6):1043-50. PubMed ID: 7769426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]